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Abstract
Pomegranate  (Punica  granatum  L. formerly  in  Punicaceae  family)  considered  to  be
super food worldwide, belongs to the family Lythraceae. It is primarily cultivated in the
Middle East, north and tropical Africa, the Indian subcontinent, Asia and Latin America.
The  medicinal  potential  of  pomegranate  is  extensively  mentioned  in  the  ancient
literature and also used in different system of medicines for a variety of ailments. The
chemical constituents of pomegranate have increased the research concern of this fruit
in the current years. It includes a variety of bioactive compounds such as quercetin,
ellagic acid, punicalagin, pedunculagin, tannic acid, anthocyanins, rutin, catechin and
polyphenols. These components of pomegranate possess antioxidant, neuroprotective,
anti-inflammatory,  anti-angiogenic,  anticancerous,  anti-mutagenic,  cytoprotective,
cardiovascular  protective,  anti-diabetic,  anti-ulcerogenic,  hepatoprotective,
antibacterial and antifungal potentials. It can enhance the male fertility and also protect
from the UV induced skin damage. Furthermore, it also illustrate the inhibitory effects
on vital metabolic enzymes, stimulate cell differentiation and toxicological properties.
The pomegranate also impedes with numerous signalling pathways, which include Bax,
Bcl-X, Bad, ERK1/2, JNK, PI3K/AKT, mTOR, PI3K, MAPK and P38. The present review will
extensively discuss the above properties of pomegranate and its extracts, supporting the
rich nutritive and healthy advantages of the fruit belonging to the monogeneric family.
Keywords: Anticancer; Antioxidant; Cytoprotective; Therapeutic 
Citation:  Puneeth  HR,  Chandra  SSP. A  review  on  potential  therapeutic  properties  of
Pomegranate  (Punica  granatum L.).   Plant  Science  Today  2020;7(1):9-16.
https://doi.org/10.14719/pst.2020.7.1.619
Copyright: © Puneeth & Chandra (2020). This is an open-access article distributed under the
terms  of  the  Creative  Commons  Attribution  License,  which  permits  unrestricted  use,
distribution, and reproduction in any medium, provided the original author and source are
credited (https://creativecommons.org/licenses/by/4.0/).
Indexing: Plant Science Today is covered by Scopus, Web of Science, BIOSIS Previews, ESCI,
CAS, AGRIS, CABI, Google Scholar, etc. Full list at http://www.plantsciencetoday.online
Introduction
Pomegranate (Punica granatum) is  a  fruit  bearing
deciduous  shrub  or  small  tree  which  grows
between 15 to 28ft tall (1). Pomegranate is believed
to have been originated from the modern day Iran,
though  the  fruit  has  been  cultivated  since  time
immemorial  in  the  Northern  India  and
Mediterranean  region  (2).  Globally  it’s  been
cultivated in the Caucasus region and Middle East,
Tropical and North Africa, Central Asia and Indian
subcontinent.  In  America  it`s  been  cultivated  in
Arizona and California, also commercially available
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in  the  markets  of  Europe  (3).  The shrubs  or  the
small trees are particularly long lived with several
anatomical  differentiation  including  seed,  peel,
leaf, bark, flower and root, each having medicinal
benefits (4). The ripe fruit is a berry, ranging about
5-12 cm in diameter which is round in shape and
the skin is thick and reddish. The number of seeds
in the pomegranate fruit range from 200 to 1400,
each surrounded by water laden pulp (5),  which
varies in colour from white to deep red or purple.
The seeds have no arils unlike some other species
in the order, Myrtales. The sarcotesta of the seeds
are  made  of  epidermis  cells  derived  from  the
integument (6).
The  fruit  has  been  mentioned in  the  Old
Testament  of  the  Holy  Bible,  the  Babylonian
Talmud and the Jewish Torah as a  revered fruit
conferring  strength  of  fertility,  abundance  and
good luck (7). It is also found in the Egyptian and
Greek  mythology  and  was  the  emblem  of  the
Roman Emperor, Maximilian. Pomegranate gets its
name from the ancient city of Granada in Spain,
which is their symbol of victory. Pomegranate has
been widely used in the alternative and traditional
medicine.  In  Ayurveda,  the  pomegranate  is
famously known as “a pharmacy unto itself” and is
used as an antiparasitic  (8),  diarrhoea,  ulcers (9)
and considered as “blood tonic” (10). Pomegranate
is also a remedy for diabetes in the Unani system
of medicine, practiced particularly in India (11). 
The interest  in  the pomegranate  research
worldwide  has  been  evidenced  by  the  pubmed
search  from  2005  to  2019,  showing  998  articles
associated  with  its  beneficial  effects,  however
between 1950 and 1999 only 25 articles pertaining
to pomegranate were found (7, 12). The potential
of  whole  pomegranate  fruit  also  significantly
showed  antioxidant  (13,  14),  anti-inflammatory
(15),  anti-diabetic  (16),  anticancer  (17),
hepatoprotective  (18),  anti-ulcerogenic  (19),
neuroprotective  (20)  and  cardioprotective  (21)
properties.It  was  also  demonstrated  to  treat
erectile dysfunction (22), to enhance male fertility
(23), to treat oral diseases (24) and for many other
medicinal  properties.  Pomegranate  seeds  also
exhibit  properties  against  microbial  infections,
helminth  infection  and haemorrhage  (25).  Other
potential  applications  comprise  arthritis,  obesity,
Alzheimer`s disease, infant brain ischemia and UV
induced skin damage (26, 27).
Chemical constituents 
The chemical composition depends on the region
where  the  fruits  are  grown,  soil  composition,
cultivation  type  and  other  conditions  (28).
Considerable  alterations  in  the  chemical
components have been reported over the decade
of  research (29).  However most  of the medicinal
properties  of  the  fruit  are  attributed  to  the
particular  secondary  metabolites  like
ellagitannins,  ellagic  acid,  punicic  acid,
anthocyanins  like  delphinidin,  cyanidin  and
pelargonidin,  anthocyanidines,  flavonoids  and
flavones, and condensed tannins  (30, 31).The peel
of the pomegranate is a good source of minerals,
polysaccharides,  flavonoids,  ellagitanins  and
phenolic compounds (32). The edible portion of the
pomegranate  contains  mainly  water,  seeds,
phenolic compounds, anthocyanins, pectins, malate,
ascorbate,  citrate  and sugars,  mainly  glucose and
fructose in it (33). The oil extracted from the seeds
is rich in ω-3 fatty acids. It also contains palmitate,
stearic  acid,  oleic  acid,  punicic  acid,  vitamins,
proteins,  sugars,  fibres,  polyphenols and minerals
(34). Primary chemical constituents of pomegranate
are listed in the Table 1.
Table 1. Primary chemical constituents of Punica granatum
Constituent Formula
Molec
ular 
weight
Pomegranate Plant 
Parts
Anthocyanins 
Delphinidin (35) C15H11O7 303.24 Juice
Ascorbic acid (36) C6H8O6 176.12 Juice
Ellagic acid C14H6O8 302.19
Juice, seed oil (37) 
pericarp, flower
Gallic acid C7H6O5 170.12 Juice, pericarp, flower
Caffeic acid (36) C9H8O4 180.16 Juice, seed oil, pericarp
Catechin C15H14O6 290.27 Juice, pericarp
EGCG (38) C40H30O24 894.65 Juice, pericarp
Quercitin C15H10O7 302.04 Juice, pericarp
Rutin (39) C27H31O15 595.53 Juice, pericarp
Iron (40) Fe 55.85 Juice
Amino acids C6H9N3O2 155.15 Juice
Punicic acid (41) C18H30O2 278.43
Pericarp, flower, root 
and bark
Sterols (42) Asiatic 
acid C30H48O5 488.7 Seed oil
Punicalagens (43) C48H28O30 1084.7
Pericarp, leaves, roots 
and bark
Flavanones, 
flavones (44) 
Apigenin-4′-O-β-D-
glucoside
C21H20O11 448.32 Pericarp, leaves
Anthocyanidins (45) 
Cyanidin C15H11O6 287.24 Leaves
Tannins (punicalin 
and punicafolin) C34H22O22 782.53
Leaves, roots and 
barks
Glycosides (44) 
( Luteolin and 
Apigenin)
C15H10O6 286.24 Juice, leaves
Ursolic acid (46) C30H48O3 456.70 Flower
Terpenoids (47) 
(Triterpenoids) 
Estradiol
C18H24O2 272.38 Flower, roots and bark
Piperidine alkaloids 
(48) 2,3,4,5-
tetrahydro-6-
propenyl-pyridine
C8H13N 123.20 Roots and barks
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Synergic potential of pomegranate
Most of the studies on pomegranate have been to
investigate the therapeutic potentials of bioactive
constituents.  The  most  generally  found bioactive
molecule is ellagic acid, which is found to exhibit
potential  anticancer  (49)  and  antioxidant
properties  (50)  thus  highlighting  its  role  as  the
most  significant  bioactive  molecule  in
pomegranate. However, research on quercetin (51,
52)  has made to divert on the above findings. In
fact  research  studies  confirm  the  synergistic
potential  of  whole  pomegranate  is  superior  to
ellagic acid in suppressing prostate cancer (53, 54).
Thus, the whole pomegranate extracts have found
to be more beneficial when compared to particular
bioactive molecules as such. 
Very less is known about the biochemistry
and bioavailability of ellagitannins from the food
sources. There is strong evidence that ellagic acid
is absorbed by blood plasma (55). A human study
has  investigated  the  metabolism,  absorption,
bioavailability,  and  antioxidant  effects  of
pomegranate  extracts.  In  a  clinical  trial,  three
pomegranate juice metabolites were identified in
the  plasma  –  urolithin  A,  urolithin  B,  and  an
unidentified small metabolite; urinalysis revealed
six  metabolites  –  the  above  three  found  in  the
plasma and an aglycone metabolite  analogous to
each  of  three  plasma  metabolites.  Maximum
excretion rates were observed 3-4 days after juice
consumption.  Important  variability  of  urinary
metabolite  concentrations  was  reported  among
subjects  and may be correlated to  differences in
the  microflora  of  colonic  system,  where  the
ellagitannins  are  believed  to  be  metabolized
(56).The determination of urolithin A and B in the
urine  may  suggest  for  pomegranate’s  prolonged
antioxidant  properties,  relatively  to  the
polyphenols in the juice.
Mechanism of action and health benefits
Human  gut  contains  about  hundred  trillion
microorganisms (57).  The bacteria supply the host
with  colonization  resistance  against  pathogens,
excite the host immune system, avert allergies and
tumors, generate vitamins, metabolize cholesterol,
and  boost  mineral  bioavailability  (58,  59).
Nevertheless,  the  overgrowth  of  these  usually
beneficial  bacteria can lead to intestinal diseases
and  also  been  related  with  cancer,  obesity  and
other related ailments  (60).  Ellagitannins present
in  pomegranate  juice  act  together  with  the
microflora of the gut. Punicalagins are known to
inhibit the growth of pathogenic microorganisms
like  Clostridia species, Pseudomonas
aeruginosaand  Staphylococcus  aureus, but  are
beneficial  for  the  growth  ofmicroorganism  like
bifido  bacterium  species including  generation  of
short chain fatty acids (61, 62) which are reported
to  exhibit  positive  effects  by  activation  of
peroxisome  proliferator-activated  receptors
(PPARs). 
PPARs  are  the  receptors  for  endogenous
lipid molecules and targets for drugs against type 2
diabetes  (63,  64) and  are  also  reported  to  be
promising  molecules  for  prevention  of
inflammatory  disorders  (65).  PPARs  are
transcription factors which belong to the nuclear
hormone  receptor  family  with  more  than  40
members recognized in the human genome. They
control gene expression by binding to Retinoid X
Receptor  (RXR)  as  a  heterodimeric  partner  to
specific  DNA  sequence  elements  known  as
Peroxisome proliferator response element (PPRE)
(66).  PPARs are  the  major  regulator  of  lipid  and
carbohydrate  metabolism,  inflammation  and
immunity (67). 
PPAR have three known isoforms: α, β or δ,
and γ, of which PPARα is vital in the clearance of
circulating or cellular lipids through the control of
gene expression during lipid metabolism. PPAR β/δ
plays  an  important  role  in  lipid  oxidation,  cell
proliferation  and  PPARγ is  reported  to  promote
adipocyte  differentiation  to  increase  the  blood
glucose uptake (68). The molecular expression and
activation  is  reported to  be  controlled by  varied
forms  of  natural  and  synthetic  molecules,
including nutrients, micro and macro element, and
drugs like thiazolidinediones (TZD) (69). However,
TZD  class  of  antidiabetic  drugs  are  likely  to  be
rejected by physicians  due  to  followed ill  effects
(70) including hepatotoxicity, obesity, edema, and
congestive heart failure (71). Consequently, the use
of  natural  molecules  which  are  able  to  activate
PPARs  can  be  safer  alternative  to  synthesized
drugs. 
Antioxidant mechanism
An earlier study have reported that pomegranate
extracts have 2-3 times the antioxidant potential to
that  of  either  red  wine  or  green  tea  (72).  In
another  investigation  pomegranate  extracts  have
exhibited  free  radicals  scavenging  activity  and
decreased macrophage  oxidative  stress  and lipid
peroxidation in laboratory animal models (73) and
enhance  the  plasma  antioxidant  capacity  in
humans  (74).  Studies on animal models  revealed
the antioxidant potentials of pomegranate extracts
prepared  from  whole  fruit  sans  the  juice,
exhibiting  a  20-percent  reduction  in  oxidative
stress  in  mouse  peritoneal  macrophages  (MPM),
and a 53-percent increase in reduced glutathione
levels  (73).  Fermented pomegranate juice  extract
has  exhibited  higher  antioxidant  capacity
compared to red wine and green tea extract  (75).
Another study on rats with carbon tetra chloride
induced  liver  damage  with  pre-treated
pomegranate  peel  extract  increased  the  free-
radical  scavenging  activity  of  the  catalase  and
super  oxide  dismutase  which  resulted  in  50-
percent decreased lipid peroxidation compared to
standards (76). 
A report on human trails that were made
to  consume  PPJ  has  exhibited  increased
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antioxidant potential compared to the apple juice.
Another  investigation  found  that  daily
consumption of 250 ml PPJ for four weeks given to
healthy  subjects  resulted  in  enhanced  plasma
antioxidant capacity from 1.33 mmol to 1.46 mmol,
whereas  subjects  consuming  apple  juice  showed
no considerable increase in antioxidant property.
Concentration of vitamin E, Vitamin C and reduced
glutathione  values  did  not  change  remarkably
across  different  groups.  This  results  extensively
indicated  pomegranate  secondary  metabolites,
may  be  responsible  for  the  significant
observations.
Antiproliferative mechanisms
Various  studies  have  revealed  that  pomegranate
extracts  (juice,  peel)  significantly  inhibit  cancer
cells and proliferation by disrupting cell cycle thus
inducing apoptosis,  finally suppressing growth of
tumor  (77).  Investigation  on prostate  cancer  cell
lines  DU-145,  LNCaP,  and  PC-3  have  exhibited
antiproliferative activity, thereby shown different
combinations of pomegranate extracts were more
effective than any single extract (78). Investigation
on animal models against prostate cancer PC-3 cell
line  resulted  in  pomegranate  extracts  inhibiting
cell  proliferation  and  induces  apoptosis  through
regulation  of  proteins  which  control  apoptosis
(79). 
Many studies have revealed the association
between  increased  cell  proliferation  and
cyclooxygenase 2 (COX-2) expressions  (80). COX-2
is a vital enzyme for the conversion of arachidonic
acid  to  prostaglandins,  which  are  important
inflammatory  mediators.  PME  and  punicalagin
decreased  COX-2  expression  in  HT-29  cells  in  a
dose-dependent  approach,  which  are  most
possibly due to remarkable interactions with other
bioactive  secondary  metabolites  for  instance
anthocyanins.  Another  study  has  reported  that
COX-2  expression  in  HT-29  cells  is  NF-κB
dependent.  These  studies  indicate  that
pomegranate  juice  extracts  have  reduced  COX-2
expression  by  inhibiting  phosphatidylinositide  3-
kinases  (PI3K)  and  protein  kinase  B  which  is
essential for NF-κB activation (81). 
Pomegranate  extracts  were  also  reported
to  decrease  lipoxygenase,  an  enzyme  which
catalyzes  the  change  of  arachidonic  acid  to
leukotrienes, which are known vital inflammatory
mediators  (75),  consequently,  pomegranate
consumption  changes  eicosanoid  biosynthesis.
Flavonoids present in pomegranate juice extracts
have  shown  20–30%  inhibition  of  soybean
lipoxygenase although no remarkable inhibition of
sheep  cyclooxygenase  was  found.  Pomegranate
juice  is  also  known  to  restrain  inflammatory
cytokine  expression  (82) and also  inhibit  matrix
metalloproteinases  (MMPs)  in  colon  cancer
condition (83). 
NF-κB, a pro-inflammatory pathway is also
known to be downregulated by pomegranate juice
injestion  and  activation  of  NF-κB  has  been
reported  in  a  number  of  cancer  cell  lines  (84),
consequently  leading  to  inflammation  and  cell
proliferation through upregulation of collagenase,
and pro-inflammatory cytokines like TNF-α (tumor
necrosis  factor),  IL-1 (interleukin),  IL-2,  IL-6,  and
IL-8  (85).  Therapeutic  properties  of  pomegranate
fruit  extracts  have  potential  anti-inflammatory
property  and  anticancer  potential,  as  they  have
been reported to diminish the generation of IL-6
and IL-8 and thus inhibit NF-κB in mast cells and
basophils.  Pomegranate  extracts  on  action  with
urolithin  A  is  known  to  decrease  few  pro-
inflammatory markers  such  as  iNOS,  COX-2,  and
prostaglandin E2 in a colon cancer cells (86). 
Current  investigations  have  reported  that
pomegranate juice extracts reduce angiogenesis by
down  regulating  vascular  endothelial  growth
factor in MCF-7 breast  cancer cell  lines.  Another
study exhibited how the pretreatment with dietary
pomegranate  oil  reduced  the  occurrence  and
increase  of  colonic  adenocarcinomas  in
azoxymethane-induced colorectal cancer cells (87).
Remarkably,  the  inhibition  of  tumor  occurrence
correlated  with  improved  expression  of  PPARγ
protein  in  the  nontumormucosa.  In  a  clinical
phase II study, in vitro assays using patient plasma
and serum demonstrated remarkable reduction in
prostate  cancer  cell  line  proliferation  and
increased  apoptosis.  Administration  of
pomegranate polyphenols  significantly correlated
nitric  oxide  preservation  with  decreased  PSA
values.  These  results  demonstrate  pomegranate
juice  extracts  may  affect  prostate  cancer  cells
because  of  antiproliferative,  apoptotic,
antioxidant, and anti-inflammatory effects (88).
Conclusion
The present researchers are focussing on natural
sources with a range of medicinal properties with
selective  targets  and  minimal  side  effects.
Pomegranate  has  been  found  to  be  one  of  the
excellent sources with diverse biological activities
including  antioxidant,  anti-inflammatory,  anti-
diabetic,  anticancer,  hepatoprotective,
cardioprotective,  neuroprotective  and  anti-
ulcerogenic  properties.  Clinical  trials  are  in
advancement to  investigate  the beneficial  effects
of  the  pomegranate  extracts.  A  number  of
applications  of  pomegranate  in  pharmaceuticals
have  been patented from many  scientists  across
the  world  which  reflects  the  scope  of  the
pomegranate in the pharmaceutical industries (89,
90).
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